Register of
Medicinal Products
Human medicines
Veterinary medicines
Medical nutritions
User
Listings
Data download
Veterinary medicines
Search for medicinal products
Search for packages
ATC tree
Print
ALFUZOSIN-TEVA
General data
Product class:
Authorized package
Medicinal product class:
For human use
Package code:
1278176
Name of medicinal product:
ALFUZOSIN-TEVA
Active substances:
Alfuzosin
Estonian
,
English
,
Latin
ATC code:
G04CA01
Dosage form:
prolonged-release tablet
Route of administration:
oral use
Strengh:
10mg
Amount in package:
30TK
Legal status for supply*:
Subject to medicinal prescription
Class of active substance:
Additional information:
Indication:
Treatment of the functional symptoms of benign prostatic hyperplasia (BPH).
Safety features:
Yes
Summary of product characteristics (SPC):
(last updated April 18, 2023)
Package information leaflet (PIL):
EST
(last updated April 18, 2023)
Labelling:
(last updated April 18, 2023)
Last imported to Estonia:
November 28, 2023
Marketing authorization
Marketing authorization holder:
Teva Pharma B.V.
Marketing authorization number:
556507
Marketing authorization issued on:
August 24, 2007
Marketing authorization expires on:
Unlimited
Marketing authorization procedure type:
Mutual recognition
Reimbursements
Percent
Valid from
Valid until
Valid
Diagnosis
Doctor's speciality
Primary
Age
Other
100
24.10.2023
Yes
No
until 4 years
50
24.10.2023
Yes
No
Prices
Reference price:
11,20 EUR
Under reference price:
Yes
Reference price of daily dose:
0,28 EUR
Entry/Changing date: October 25, 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader from
here